You are here


2019 Technology Showcase

Primary tabs


Event graphic that states 2019 Technology Showcase National Cancer Institute and Frederick National Laboratory

It was great seeing you on June 12. Thank you for a great event!

IN THE NEWS: Hear about what was said about this event

BioBuzz: "Frederick National Labs Attract Entrepreneurs and Collaborators Seeking Leading-Edge Biomedical Technologies"

The Frederick News-Post: "Frederick Research Centers Look to Advance Technology Through Partnerships"

Event Overview:

The 2019 Technology Showcase highlighted technologies being developed at the NCI and Frederick National Laboratory for Cancer Research (FNLCR) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients.

  • Free, half-day event
  • Hear from NCI and FNLCR inventors about technologies primed for technology commercialization and/or collaboration; great opportunity for regional companies and biotech stakeholders.
  • Panel sessions focused on technology commercialization
  • Poster session highlighting NIH technologies for available for collaborative development and/or licensing presented by the NCI Technology Transfer Ambassadors Program 
  • Networking, including event following the Tech Showcase

Date and Location:

Wednesday, June 12, 2019
Check-in / Registration 11:30 am - Noon
Noon - 5:00 pm (post-showcase networking event to follow)
FNLCR Advanced Technology Research Facility
8560 Progress Drive
Frederick, MD 21702


Welcome & Keynote Speaker:

Noon - 12:30 pm

Rich Bendis, President and CEO of BioHealth Innovation, Inc.
Richard Bendis, President and CEO of BioHealth InnovationMr. Bendis is the Founder, President and CEO of BioHealth Innovation, Inc. He is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker and consultant in the technology and healthcare industries. He currently serves as the founding President and CEO of Innovation America (IA), a national public-private partnership focused on accelerating the growth of innovation economy in America. As one of the most recognized experts in the field of innovation economy, Mr. Bendis has served on numerous distinguished boards and task forces including the White House U.S. Innovation Partnership Advisory Task Force, the Small Business Innovation Research Committee, the National Association of State Venture Funds board; State Science and Technology Institute, and the Ernst and Young Entrepreneurial Institute as a national/regional Judge and Entrepreneur of the Year winner.

Featured Technologies:

The 2019 agenda features two Technology Sessions.
Technology Presentation Session 1: 12:30 - 1:25 pm
Technology Presentation Session 2:   3:10 - 4:00 pm 

Chuong Hoang, M.D. , NCI CCR, Thoracic Surgery Branch – "Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery" (E-080-2018)
Marina Dobrovolskaia, Ph.D., FNLCR Nanotechnology Characterization Lab – “Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation” (E-069-2018)
Nan Li, Ph.D., NCI CCR, Laboratory of Molecular Biology – "High Affinity Monoclonal Antibodies Targeting Glypican-1" (E-028-2019)
Kumaran S. Ramamurthi, Ph.D., NCI CCR Laboratory of Molecular Biology – "Nanoparticle Platform Using Bacterial Spore Coat Proteins" (E-098-2015)
Dominic Esposito, Ph.D., FNLCR RAS Initiative – “New Insect Cell Technologies for Improved Protein Production” (E-287-2012, E-009-2015, E-146-2017)
Nadya Tarasova, Ph.D., NCI CCR Cancer and Inflammation Program – "Synthetic Lipopeptide Inhibitors of RAS Oncoproteins" (E-293-2010)
De Yang, M.D., Ph.D., NCI Center for Cancer Research (CCR), Cancer and Inflammation Program – "Therapeutic Antitumor Combination Containing TLR4 Agonist HMGN1" (E-069-2016)
Stephan Stern, Ph.D., FNLCR Nanotechnology Characterization Lab – “Polymeric Delivery Platform for Therapeutics” (E-097-2017)
Josip Blonder, M.D., FNLCR Antibody Characterization Laboratory – “Renal Carcinoma Biomarkers” (E-317-2008)

Panel Sessions:

The 2019 agenda includes the addition of two sets of technology commercialization-focused panels.

Panel Session One:
1:30 - 2:25 pm

The following panels will be offered concurrently. Attendee selects one. Time is subject to change.

"Making your company attractive to equity investors"​

Martin Rosendale, CEO, Maryland Technology Council

Phillip Jung, Associate Maryland Venture Fund
Matthew Miessau, Analyst, Epidarex Capital

"Partnering with the NCI and FNL to benefit your pipeline and your bottom-line"

Michael Salgaller, Ph.D., Supervisor, NCI Technology Transfer Center (TTC), Invention Development and Marketing Unit

Andrew Ishizuka, Ph.D., CSO, Avidea Technologies, Inc.
Vladimir Popov, Ph.D., Director, Partnership Development Office at Frederick National Laboratory for Cancer Research              
Thomas Stackhouse, Ph.D., Director, NCI TTC

Panel Session Two:
4:05 - 4:55 pm

The following panels will be offered concurrently. Attendee selects one. Time is subject to change.

"Non-dilutive sources of funding for commercializing technology"  

Darryl Sampey, Ph.D., President and CEO, BioFactura  

Christie Canaria, Ph.D., Program Director, NIH/NCI/SBIR Development Center
Barry Datlof, M.B.A., Chief, Business Development and Commercialization, US Army Medical Research and Materiel Command
Javeed Froozan, VP, Research Business Development & Strategic Alliances, Leukemia & Lymphoma Society

​"Leveraging incubators and accelerators for technology licensing and commercialization”

Michael Binko, President and CEO, Startup Maryland 

Kathie Callahan Brady, President and CEO, Frederick Innovative Technology Center, Inc. (FITCI)
Rosemarie Truman, Founder and CEO, the Center for Advancing Innovation
Jon A. Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio, Inc.

Technology Transfer Ambassadors Program (TTAP)
Lightning Poster Pitch:

2:25 - 2:40 pm
followed by Networking / Poster Session - 2:40 - 3:10 pm
Posters prepared by TTAP Ambassadors will highlight the following technologies that are available for licensing and/or partnering:
1. Presented by 2017 Ambassador Alum, David Wei, Ph.D.
Inventor: Bruce Shapiro, Ph.D., NCI Center for Cancer Research (CCR) RNA Biology Laboratory – Nanoparticles for the Targeted Treatment of Infected Cells” (*E-039-2012) 
*2. Presented by 2018 Ambassador Alum, Jyoti Roy, Ph.D.
Inventor: Haksong Jin, PharmD, MS “Topical Sodium Nitrate Ointment for Sickle Cell Disease” (E-149-2014)
*3. Presented by 2019 TTAP Ambassador, Sanket Awate, Ph.D.
Inventor: Arya Biragyn, Ph.D , National Institute on Aging (NIA), Laboratory of Molecular Biology and Immunology – “Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease” (E-101-2010)
4. Presented by 2019 TTAP Ambassador, Sanket Awate, Ph.D.
Inventor: Christopher Ramsden, M.D., NIA, Laboratory of Clinical Investigation / Lipid Peroxidation Unit – “Fatty Acid Derivatives and Their Use” (E-151-2017)
5. Presented by 2019 TTAP Ambassador, Mukta Nag, Ph.D.
Inventor: George Pavlakis M.D., Ph.D., NCI CCR, Vaccine Branch – “Conserved Elements Vaccine for HIV” (E-132-2012)
*6. Presented by 2019 TTAP Ambassador, Suna Gulay, Ph.D.
Inventor: Kenzie Preston, Ph.D., National Institute of Drug Abuse (NIDA), Clinical Pharmacology and Therapeutics Research Branch – "A Mobile Health Platform" (E-049-2015)
7. Presented by 2019 TTAP Ambassador, Suna Gulay, Ph.D.
Inventor: James Kochenderfer, M.D., NCI CCR Experimental Transplantation and Immunology Branch – “Anti-SLAMF7 Chimeric Antigen Receptors” (E-158-2018)
8. Presented by2019TTAP Ambassador, Devanand Bondage, Ph.D.
Inventor: Louis Staudt, M.D., Ph.D., NCI CCR Lympoid Malignancies Branch – “Using a Proximity Ligation Assay to Diagnose Lymphoma Subsets and Predict Patient Responses to Targeted Therapies” (E-171-2017)
9. Presented by 2019 TTAP Senior Ambassador and 2018 TTAP Alum, Sarwat Naz, Ph.D.
Inventor: David Roberts, Ph.D., NCI CCR Laboratory of Pathology – “Method for Generating Pluripotent and Multipotent Cells” (E-086-2012)

*10. Presented by 2017 Ambassador Alum, Delphine Lissa, Ph.D.
Inventor: Jeffrey Baron, M.D., NICHD, Section on Growth and Development – “Diagnostic Assays for the Detection of Thyroid Cancer” (E-016-2013)

*Select posters were developed through the TTAP partnership with the Johns Hopkins University (Carey Business School) “Discovery to Market” course
Event Co-Sponsors:

    NCI Technology Transfer Center; Frederick National Laboratory for Cancer Research; Frederick County Office of Economic Development; City of Frederick Department of Economic Development; TEDCO

    Learn about previous Technology Showcases
    Monday, January 9, 2023